Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Get involved with other Networks, Consortia, Initiatives and Groups within the University

Networks

Oxford Single Cell Biology Consortium     single-cells.jpeg

The aim of the OSCBC is to rapidly apply advances in single-cell technologies to improve the diagnosis, stratification and treatment of human diseases. The OSCBC includes over 30 interactive research groups across the Oxford Biomedical Institutes and Science Departments working on a wide range of different areas.

The OSCBC also houses a number of state of the art technology platforms housed in two single-cell facilities based at the Weatherall Institute of Molecular Medicine (WIMM) and the Oxford Genomics Centre at the Wellcome Trust Centre for Human Genetics. (WTCHG).

 

Oxford Biomedical Imaging NetworkBiomedical Imaging Network

The aim of the Network is to provide a forum for improved communication and collaboration between the diverse members of the Oxford University imaging community. This comprises expertise across a huge range of imaging scales (cellular microscopy to human whole body imaging), modalities (e.g. optical microscopes, nuclear medicine imaging techniques, magnetic resonance imaging, ultrasound), and disease areas (e.g., oncology, clinical neuroscience, cardiovascularmedicine and musculoskeletal).

 

Oxford Rare Disease Initiative      ORDI

The University of Oxford together with the Oxford University Hospitals Trust (OUH) have outstanding expertise and capabilities in rare diseases with more than 250 scientists working on over 350 different rare diseases.

The Oxford Rare Disease Initiative (ORDI) brings together this expertise to create an extensive rare disease network, and provides assistance in establishing collaborations between Oxford rare disease researchers, industry, patient organisations and funders.

 

Oxford Immunology Group      Oxford Immunology Group

OIG is a regional group of the British Society for Immunology based in Oxford.  We organize annual meetings, with the help of the BSI, with the particular aim of trying to attract visiting speakers with the widest appeal, but to also advertise the best in local immunological research. Our aim is to promote collaboration among Immunologists in Oxford and the whole UK.

 

QBIOX      QBIOX

QBIOX is an interdisciplinary network that fosters a culture of quantitative research in the biosciences with a focus on applications in developmental biology, cancer and tissue engineering where similar cell- and tissue-level processes are at play and, hence have common theoretical methodologies.

By bringing together biomedical and physical scientists, QBIOX aims to exploit synergies between the application areas and facilitate the formation of large and coherent multidisciplinary consortia of researchers who share a commitment to making biology and medicine quantitative, and who possess the depth and range of specialist knowledge needed to effect a step-change in understanding in these areas.

 

EuromabnetEuroMAbNet

EuroMAbNet is a network of European laboratories that provides an arena in which people working in the field of monoclonal antibody production and technology can exchange knowledge, share the most up-to-date methodology and create common strategies to both standardize and improve the production of properly validated monoclonal antibodies.

 

Oxford Bioresource     Oxford BioResource

An umbrella organisation enabling access to consented, high quality bioresources, associated clinical data, pathology expertise, services and advanced technologies in molecular diagnostics.

 

Validate NetworkVALIDATE Network 

VALIDATE is an international network of researchers developing vaccines against globally significant diseases caused by complex intracellular pathogens. Our initial focus is on tuberculosis (TB), leishmaniasis, melioidosis, and leprosy, which cause substantial mortality and morbidity across the globe, particularly in low and middle-income countries (LMICs). By working together, we will advance research more quickly and effectively.

 

Africa Oxford InitiativeAFOX Initiative

The Africa Oxford Initiative (AfOx) is a cross-university platform for academic and research collaborations between the University of Oxford and African researchers and institutions. The Initiative aims to support the work of universities and research institutions across Africa and to facilitate the development of equitable and extensive collaborations between Oxford and African institutions.

 

Image courtesy of www.shutterstock.com